Clinical Trial Update: G-Pola-ZLP in Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates the G-Pola-ZLP regimen for Diffuse Large B-Cell Lymphoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• G-Pola-ZLP

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING